Industry / innovation partners

Why some “resistant” hypertension isn’t resistant at all, and what cardiology might be missing

Desmoid Tumours Are Not Benign to the People Living With Them

Pancreatic Cancer Is Forcing Regulators to Move Faster

When Dementia Takes Speech, Trials Must Catch Up

Ultra-processed food may leave a metabolic fingerprint in the blood.

New global heart failure definition exposes a policy gap: systems still diagnose too late and treat too narrowly

Sugar substitutes were sold as metabolic shortcuts. The evidence is getting harder to ignore

Pancreatic Cancer’s ADC Moment Will Live or Die by the Biomarker

Merck KGaA’s Saturnus Bio bet signals a shift to genotype-driven cardiology, and a looming readiness gap for health systems
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
